Showing 1 - 10 of 4,318
One of the reasons why regulators are hesitant about permitting price competition in healthcare markets is that it may damage quality when information is poor. Evidence on whether this fear is well-founded is scarce. We provide evidence using a reform that permitted Dutch health insurers and...
Persistent link: https://www.econbiz.de/10011823733
Persistent link: https://www.econbiz.de/10009160890
Persistent link: https://www.econbiz.de/10011947591
Persistent link: https://www.econbiz.de/10012164267
Persistent link: https://www.econbiz.de/10013444005
Persistent link: https://www.econbiz.de/10014328732
Persistent link: https://www.econbiz.de/10000539552
Persistent link: https://www.econbiz.de/10011432227
Persistent link: https://www.econbiz.de/10009618014
Persistent link: https://www.econbiz.de/10010238024